CDK2 and melanoma: When mutated, MITF increases its activity, leading to an increase in transcription factors such as CDK2 (cyclin-dependent kinase 2), and CDK2 is responsible for the cell cycle regulation [3,27], and it was observed that the depletion of CDK2 suppressed the cell growth and cell cycle progression in melanoma [29].